Skip to main content
Ritamix Global Limited logo

Ritamix Global Limited — Investor Relations & Filings

Ticker · 1936 ISIN · KYG7576R1020 HKEX Manufacturing
Open in API
Filings indexed 255 across all filing types
Latest filing 2024-01-26 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1936

About Ritamix Global Limited

http://www.ritamix-global.com

Ritamix Global Limited is engaged in the distribution and manufacturing of nutritional products, primarily specializing in animal feed additives and premixes, and secondarily, in the distribution of human food ingredients. The company develops and produces over 150 proprietary animal feed additives premixes and distributes more than 300 branded products from external suppliers. With over two decades of industry experience, Ritamix serves feedmills, farms, and related industries by providing essential inputs for animal and human nutrition.

Recent filings

Filing Released Lang Actions
Letter to Registered Shareholders and Reply Form - Mandatory Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 95% confidence The document is a letter to shareholders regarding the mandatory electronic dissemination of corporate communications pursuant to amended listing rules. It explains how future corporate communications such as directors' reports, annual accounts, interim reports, notices of meetings, circulars, proxy forms, and other communications will be distributed electronically via the company's and HKEx's websites. It includes a reply form for shareholders to provide their email addresses and consent to electronic delivery. There is no actual financial data, financial statements, or detailed report content included. The document is an announcement about the method of distribution of corporate communications rather than the communications themselves. It is also not a certification or legal proceeding. The document is relatively short and serves as a notification to shareholders about changes in communication methods. Therefore, it fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about compliance with listing rules and communication procedures, not a report or financial statement itself.
2024-01-26 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return report submitted to the Hong Kong Exchanges and Clearing Limited regarding movements in securities, specifically detailing movements in authorised/registered share capital, issued shares, share options, and confirmations related to securities issued. It is a regulatory compliance filing related to share capital and securities movements rather than a financial report, earnings release, or management discussion. The document is structured as a formal regulatory submission with confirmations by the company secretary. It does not contain financial statements, earnings data, or management commentary. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-01-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Regulatory Filings Classification · 100% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 November 2023. It details movements in authorised/registered share capital, issued shares, share options, and confirms compliance with listing rules. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting monthly share capital and share issuance movements. It does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report publication but a regulatory filing of share capital movements. Therefore, it fits best under Regulatory Filings (RNS).
2023-12-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return report detailing movements in authorised and issued share capital, share options, and confirmations related to securities issued by the company. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with listing rules. The content focuses on share capital changes and confirmations rather than financial performance, management changes, or earnings. It is a regulatory compliance filing related to share capital movements and confirmations, not a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2023-11-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return regarding movements in securities, specifically focusing on authorized and issued shares, share options, and confirmations related to securities issued by the company. It is submitted to the Hong Kong Exchanges and Clearing Limited and references compliance with listing rules. The content is about share capital movements and confirmations rather than financial performance, earnings, or management commentary. It does not contain financial statements or earnings data, nor is it a report or presentation. The document fits the description of a Share Issue/Capital Change announcement, as it details changes (or lack thereof) in share capital and share options for the month ended 30 September 2023.
2023-10-04 English
UPDATE ON EXPECTED TIMELINE FOR USE OF PROCEEDS
Capital/Financing Update Classification · 95% confidence The document is an announcement from Ritamix Global Limited regarding an update on the expected timeline for the use of proceeds from its listing. It references previous announcements and reports, including the prospectus, annual report, and interim results, but primarily focuses on the status and revised timeline for utilizing the net proceeds from the IPO. The content details the allocation and unutilized amounts of proceeds, reasons for delays, and future expectations. There are no financial statements or comprehensive financial data presented, nor is this a full annual or interim report. The document is an update on capital use and timeline revisions, which fits the category of Capital/Financing Update (CAP). The length and detail confirm it is not a brief report publication announcement or a regulatory filing. Therefore, the classification is CAP with high confidence.
2023-09-27 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.